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Unstable mouse tumors, a mine for 
human cancer genes
Although mouse cancer models have been established, most 
genetically engineered murine cancers exhibit relatively 
benign cytogenetic profiles. Thus, in order to uncover genomic 
alterations involved in mouse cancer ontogeny, Maser and col-
leagues generated a murine T-cell lymphoma model with both 
telomere and checkpoint defects. This inherent genome insta-
bility yielded genomic alterations similar to those observed in 
human hematopoietic, mesenchymal, and epithelial cancers. 
Specifically, comparative cross-species oncogenetic studies 
and resequencing revealed syntenic copy number alterations 
in loci altered in human cancers. In addition, this analysis 
identified FBXAW7 and PTEN as genes commonly mutated 
in T-cell lymphoma. Overall, these results support the use of 
genomically unstable murine tumor models for mining human 
genomic cancer alterations. (Nature 447:966–71, 2007)
Epidermal T-cell migration in psoriasis
Psoriasis, one of the most common T-cell-mediated chronic 
inflammatory diseases, involves activated epidermal T cells. 
Because the extracellular matrix and its associated collagen 
molecules form the structure of human skin, Conrad and col-
leagues recently explored the functional role of collagen- 
binding integrins on activated T cells. T cells isolated from 
psoriatic lesions expressed α1β1 integrin in the epidermis but 
not in the dermis. These cells expressed interferon-γ but not 
interleukin-4, thereby identifying them as epidermal type I 
effector memory T cells. Blockade of the α1β1 integrin via a 
monoclonal antibody in a xenotransplantation model not only 
inhibited T-cell migration but also abrogated development of 
psoriasis acanthosis and papillomatosis. These effects on psori-
asis symptoms were similar to those following administration of 
tumor necrosis factor-α, a common psoriasis treatment. These 
findings indicate the relevance of the interactions between the 
epidermal extracellular matrix collagens and T cells in early 
psoriasis development. (Nat Med 13:836–42, 2007)
STAT3 function in hyper-IgE syndrome
Following the discovery of a mutation in the tyrosine kinase 
2 gene in a patient with hyperimmunoglobulin E syndrome 
(HIES), Minegishi and colleagues probed genes involved in 
other cytokine signaling pathways. Human signal transducer 
and activator of transcription 3 (STAT3)—a molecule at the 
crossroads of a wide variety of cytokine, growth factor, and 
hormone response pathways—was found to harbor mutations 
in 8 of 15 HIES patients examined. These mutations appeared 
to occur de novo, because parental and sibling samples did 
not contain the mutations. The mutations were localized 
to the DNA-binding domain and thus impaired the DNA- 
binding activity of STAT3. In addition, the STAT3 mutations 
exhibited dominant-negative effects in a luciferase reporter 
assay in cultured cells coexpressing wild-type STAT3. The dis-
covery of STAT3 mutations in HIES patients underscores the 
involvement of multiple cytokine pathways in the pathogen-
esis of HIES and offers a mechanism for early diagnosis of this 
immunodeficiency disease. (Nature 448:1058–62, 2007)
Activation of transcriptional pathways 
restores EB
Epidermolysis bullosa (EB), a rare disease in which epidermal 
integrity is lost following mechanical trauma, is commonly 
caused by dominantly acting mutations in keratin 5 (K5) or 
K14. These proteins function as components of the cytoskele-
tal intermediate filaments in basal keratinocytes of the epider-
mis. Recently, Kerns and colleagues triggered the activation of 
two distinct transcriptional pathways, Gli2 and Nrf2, in mice. 
Ectopic expression of Gli2, a terminal effector of hedgehog 
signaling, resulted in normal skin K14-deficient mice. These 
mice displayed upregulation of K17, which is highly homol-
ogous to K14. Furthermore, the use of sulforaphane to acti-
vate Nrf2 transcription yielded increased K17 expression and 
reduced cutaneous blistering in K14-deficient mice. The mini-
mal overlap in these two pathways implicates the induction 
of K17 in basal epidermal keratinocytes as a critical factor in 
restoring the skin under EB conditions. Thus, the use of Nrf2 
inducers such as sulforaphane may be an effective therapeutic 
strategy for EB patients with a mutation in the K14 locus. (Proc 
Natl Acad Sci USA 104:14460–5, 2007)
Pigment recipient in charge
Although much effort has been made toward understand-
ing the production of pigment, little is understood about 
the effectors of pigment patterning. Weiner and colleagues 
thus investigated the role of the epithelial pigment recipi-
ent cells in determining the behavior of melanocyte pigment 
donor cells. In epithelial progenitor populations, expression 
of transgenic Foxn1, a murine gene essential for epithelial 
tissue development, targeted melanocytes to the epidermal 
cells and dictated the pigmentation pattern. Foxn1 expres-
sion induced both expression and secretion of fibroblast 
growth factor 2 (Fgf2), a transcription factor known to affect 
melanocyte behavior and pigmentation. Inhibition of Fgf2 
activity in Foxn1 transgenic mice, however, rescued or nor-
malized the pigmentation phenotype of these mice. Thus, 
epithelial cells that express Foxn1 signal via Fgf2 (and per-
haps other signals) to melanocytes to direct the deposition 
of pigment. These results illuminate a pathway whereby the 
melanin-receiving cells dictate the pattern of melanin dona-
tion by melanocytes. (Cell 130:932–42, 2007)
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